Left Ventricular Hypertrophy Clinical Trials

12 recruiting

Left Ventricular Hypertrophy Trials at a Glance

12 actively recruiting trials for left ventricular hypertrophy are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Boston, Charlestown, and Hangzhou. Lead sponsors running left ventricular hypertrophy studies include Massachusetts General Hospital, Hospices Civils de Lyon, and Centre Hospitalier Universitaire, Amiens.

Browse left ventricular hypertrophy trials by phase

Treatments under study

About Left Ventricular Hypertrophy Clinical Trials

Looking for clinical trials for Left Ventricular Hypertrophy? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Left Ventricular Hypertrophy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Left Ventricular Hypertrophy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 4

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

HypertensionLeft Ventricular Hypertrophy
Brigham and Women's Hospital75 enrolled1 locationNCT05593055
Recruiting
Not Applicable

Evaluation of Left Ventricular Ejection Fraction Using an Accelerated Cardiac Cine-MRI Sequence With Deep Learning-based Image Reconstructions

Deep LearningCardiac Magnetic Resonance ImagingLeft Ventricular Hypertrophy+2 more
Centre Hospitalier Universitaire, Amiens61 enrolled1 locationNCT07061821
Recruiting
Not Applicable

Imaging Histone Deacetylase in the Heart

DiabetesAortic Valve StenosisHeart Failure With Normal Ejection Fraction+1 more
Massachusetts General Hospital96 enrolled1 locationNCT03549559
Recruiting
Early Phase 1

Diffusion MRI in Heart Failure

Heart FailureMyocardial InfarctionLeft Ventricular Hypertrophy
Massachusetts General Hospital160 enrolled1 locationNCT02973633
Recruiting

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Autonomic DysfunctionHypertensionBlood Pressure Disorders+15 more
Wake Forest University Health Sciences125 enrolled1 locationNCT04752293
Recruiting

AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy (HCM)Left Ventricular Hypertrophy
Second Affiliated Hospital, School of Medicine, Zhejiang University15,000 enrolled1 locationNCT07263204
Recruiting

US Benchmarking Clinical Study

Cardiac AmyloidosisHFpEF - Heart Failure With Preserved Ejection FractionHFmrEF+2 more
eMyosound SAS150 enrolled3 locationsNCT07215715
Recruiting

Postnatal Steroids Effects on Cardiac Function in Extremely Preterm

Left Ventricular Hypertrophy
McGill University Health Centre/Research Institute of the McGill University Health Centre21 enrolled1 locationNCT04644094
Recruiting
Not Applicable

Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy

Left Ventricular Hypertrophy
Yale University200 enrolled1 locationNCT05730309
Recruiting
Not Applicable

Sodium Lowering Vascular Effects Trial

Endothelial DysfunctionVascular StiffnessLeft Ventricular Dysfunction+1 more
Tulane University256 enrolled1 locationNCT05388032
Recruiting

Response of the Myocardium to Hypertrophic Conditions in the Adult Population

HypertensionLeft Ventricular HypertrophyMyocardial Fibrosis
National Heart Centre Singapore2,000 enrolled1 locationNCT02670031
Recruiting

Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.

CardiomyopathiesLeft Ventricular HypertrophyHypertension Arterial+1 more
Hospices Civils de Lyon1,000 enrolled1 locationNCT05942729